Cargando…
Urinary Neurotransmitter Testing: Considerations of Spot Baseline Norepinephrine and Epinephrine [Expression of Concern]
| Formato: | Online Artículo Texto |
|---|---|
| Lenguaje: | English |
| Publicado: |
Dove
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7190331/ https://www.ncbi.nlm.nih.gov/pubmed/32426299 http://dx.doi.org/10.2147/RRU.S240215 |
| _version_ | 1783527669070036992 |
|---|---|
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-7190331 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2020 |
| publisher | Dove |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-71903312020-05-18 Urinary Neurotransmitter Testing: Considerations of Spot Baseline Norepinephrine and Epinephrine [Expression of Concern] Res Rep Urol Expression of Concern Dove 2020-04-23 /pmc/articles/PMC7190331/ /pubmed/32426299 http://dx.doi.org/10.2147/RRU.S240215 Text en © 2020 Dove Medical Press. http://creativecommons.org/licenses/by-nc/3.0/ This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php). |
| spellingShingle | Expression of Concern Urinary Neurotransmitter Testing: Considerations of Spot Baseline Norepinephrine and Epinephrine [Expression of Concern] |
| title | Urinary Neurotransmitter Testing: Considerations of Spot Baseline Norepinephrine and Epinephrine [Expression of Concern] |
| title_full | Urinary Neurotransmitter Testing: Considerations of Spot Baseline Norepinephrine and Epinephrine [Expression of Concern] |
| title_fullStr | Urinary Neurotransmitter Testing: Considerations of Spot Baseline Norepinephrine and Epinephrine [Expression of Concern] |
| title_full_unstemmed | Urinary Neurotransmitter Testing: Considerations of Spot Baseline Norepinephrine and Epinephrine [Expression of Concern] |
| title_short | Urinary Neurotransmitter Testing: Considerations of Spot Baseline Norepinephrine and Epinephrine [Expression of Concern] |
| title_sort | urinary neurotransmitter testing: considerations of spot baseline norepinephrine and epinephrine [expression of concern] |
| topic | Expression of Concern |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7190331/ https://www.ncbi.nlm.nih.gov/pubmed/32426299 http://dx.doi.org/10.2147/RRU.S240215 |